By Dennis Thompson HealthDay ReporterTHURSDAY, March 12, 2026 (HealthDay News) — People frequently switch between different weight-loss drugs, swapping Ozempic for Zepbound and vice versa within the ...

Loss of muscle mass, also called muscle wasting or atrophy, can happen gradually as part of getting older or more suddenly due to underlying medical conditions. Other factors can contribute, like ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Revolutionizing Medical Weight Loss with GLP-1 Therapy Bellingham, United States - February 25, 2026 / Mt. Baker ...

GLP-1 agonist medications (Ozempic and Wegovy) and dual GIP/GLP-1 receptor agonist medications (Zepbound and Mounjoaro) are powerful tools for weight loss, but losing weight rapidly can also lead the ...

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...

A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce broadly consistent weight-loss results across age, race, ethnicity, and ...

A new study shows that popular weight‑loss drugs may help the heart after a person has a heart attack. These drugs are already used to help people lose weight or treat diabetes. Now researchers think ...

A diabetologist attributes his 37 kg weight loss to structured exercise and metabolic correction, emphasising insulin control and sustainable habits.

Two-thirds of patients using weight loss drugs hide their treatment from loved ones, amid rising social stigma. Read more.